Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary.

International journal of cancer - 1 Jun 2000

Van Der Looij M, Szabo C, Besznyak I, Liszka G, Csokay B, Pulay T, Toth J, Devilee P, King M C, Olah E

Abstract excerpt

We have investigated the impact of BRCA1 and BRCA2 mutations that were frequently identified among Hungarian high-risk breast-ovarian cancer families (Ramus et al., 1997b, AJHG), on the development of breast and ovarian cancer in the general Hungarian population. The prevalence of 3 BRCA1 mutatio...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age of Onset
Share to BRCA1 Protein
Share to BRCA2 Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Breast Neoplasms

Share to Hungary

Share to Neoplasm Proteins

Share to Ovarian Neoplasms

Share to Prevalence

Source

Identifiers

PMID: 10797299
DOI: 10.1002/(sici)1097-0215(20000601)86:5<737::aid-ijc21>3.0.co;2-1

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-10797299-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary.PMID 10797299Read ↗

BRCA1 5382insC founder mutation has not a significative recurrent presence in Northeastern Romanian cancer patients.Semantic proximity Read ↗

High prevalence of BRCA1 founder mutations in Greek breast/ovarian families.Semantic proximity Read ↗

Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families.Semantic proximity Read ↗

Molecular genetic investigation of hereditary breast and ovarian cancer patients in the Southern Transdanubian region: widening the mutation spectrum and searching for new pathogenic variants using next-generation methods.Semantic proximity Read ↗

Frequency of three BRCA1 gene founder mutations in breast/ovarian cancer families from the Pomerania-Kujawy region of Poland.Semantic proximity Read ↗

Founder mutations in BRCA1 and BRCA2 genes.Semantic proximity Read ↗

BRCA1 1675delA and 1135insA account for one third of Norwegian familial breast-ovarian cancer and are associated with later disease onset than less frequent mutations.Semantic proximity Read ↗

Comprehensive genetic characterization of hereditary breast/ovarian cancer families from Slovakia.Semantic proximity Read ↗

Novel germline BRCA1 and BRCA2 mutations in Turkish women with breast and/or ovarian cancer and their relatives.Semantic proximity Read ↗

High frequency and allele-specific differences of BRCA1 founder mutations in breast cancer and ovarian cancer patients from Belarus.Semantic proximity Read ↗

The occurrence of germline BRCA1 and BRCA2 sequence alterations in Slovenian population.Semantic proximity Read ↗

BRCA1 and BRCA2 germline mutation spectrum and frequencies in Belgian breast/ovarian cancer familiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.